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Abstract 
A Heck cyclisation approach is described for the rapid synthesis of a library of natural product-like 
small molecules, based on the phenanthridine core. The synthesis of a range of substituted 
benzylamine building blocks and their incorporation into the library is reported, together with a highly 
selective cis-dihydroxylation protocol that enables access to the target compounds in an efficient 
manner. Biological evaluation of the library using zebrafish phenotyping, has led to the discovery of 
compound 20c, a novel inhibitor of early-stage zebrafish embryo development. 
 
Introduction 
Forward chemical genetics techniques seek to emulate the success of classical genetics by using 
small molecules to probe the function of gene-products and thus reveal information about 
biological processes.
1 
Typically, a small molecule library is screened against a cellular or 
embryonic system and the induction of any abnormal phenotype is identifed. The protein target  
that has been modulated may then be deduced;
2
 thus providing both information on its function 
and a small molecule modulator from one process. The ongoing search for modulators of all 
"druggable" targets puts heavy demands on the sourcing of small molecule libraries which may 
be obtained from in-house compound collections,
3 
commercially acquired combinatorial 
libraries,
1
 or even virtual libraries.
4
 However, many such compound collections suffer from a 
somewhat reduced scope, which has led to renewed interest in libraries based on the diverse core-
structures of natural products.
5
 These complex architectures have evolved to fulfil specific 
biological functions and, as a result of the close evolutionary relationship shared by the genomes 
of all organisms, bind to proteins similar to human proteins.
5
 Natural products are therefore 
unmatched in terms of their inherent bioactivity and their ability to probe chemical space; thus 
they represent excellent, biologically-validated scaffolds upon which to base chemical library 
design.  
 
Figure 1. The phenanthridine core 1 and biologically active phenanthridine natural products 2-4. 
Page 2 of 18 
 
Scheme 1. Heck cyclisation approach to the phenanthridine core.
9
 6a=1,2; 7a=2,3; 8a=3,4. Reagents 
and Conditions: Cationic: Herrmann-Beller palladacycle (5 mol%), Ag2CO3, DMF, 140°C, (99%, 
6a:7a:8a 83:15:2); Neutral: Herrmann-Beller palladacycle (5 mol%), MeNCy2, DMF, 140°C (95%, 
6a:7a:8a 36:38:26); or Pd2(dba)3, 
t
Bu3P•HBF4 (10 mol%), MeNCy2, MeCN, r.t.-50°C, (95%, 6a:7a:8a 
34:37:29). 
 
The phenanthridine core 1 (Figure 1) lies at the heart of many bioactive natural products 
including the antiviral lycorine 2,
6
 the tubulin polymerisation inhibitor chelidonine 3,
7
 and the 
insect anti-feedant 3-O-acetyl-narcissidine 4.
8
 We recently disclosed methodology for the 
efficient Heck cyclisation of carbamate precursor 5a (Scheme 1), to afford cis-ring fused 
phenanthridine double bond isomers 6a (1,2 alkene), 7a (2,3 alkene) and 8a (3,4 alkene) in 
excellent yield.
9
 By combining this methodology with a range of benzylamine building blocks 9 
(Scheme 2), rapid access to a collection of A-ring modified phenanthridine analogues should be 
achieved, each with an alkene handle suitable for further functionalisation. Due to the prevalence 
of hydroxylated C-ring components in bioactive phenanthridine natural products,
6-8,10
 subsequent 
functionalisation of the alkene isomers 6-8 was envisaged using a dihydroxylation protocol. In 
order to evaluate the resultant novel natural-product inspired small molecules, library synthesis 
was coupled with phenotypic evaluation in embryonic zebrafish.
11
 
 
 
Scheme 2. Proposed library synthesis. 
 
Library Synthesis 
Initial efforts focused on the synthesis of Heck cyclisation precursors incorporating a range of 
benzylamine building blocks. To this end, standard transformations were employed for the 
synthesis of benzylamines 9b-f from their commercially available benzoic acid counterparts 10b-
f (Table 1).  
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Reagents and Conditions: a) i) SOCl2, 60°C, 3 h; ii) NH4OH, r.t., 16 h; b) SOCl2, 60°C, 3 h; c) i) 
LiAlH4, AlCl3, Et2O, , 16 h; ii) HCl in Et2O. 
 
Entry 10 R=  Yield 11 
(% ) 
Yield 12 
(%)  
Yield 9 
(%) 
1 b 4-Me 95 73 80 
2 c 4-F 94 97 70 
3 d 5-OMe 73 99 65 
4 e 4,5-di-OMe 99 88 74 
5 f 3,4-CH=CH-
CH=CH- 
99 95 55 
 
Table 1. Synthesis of amine building blocks 9b-f. 
 
To access the corresponding piperonyl building block (R= 4,5 -OCH2O-), a high yielding, two-
pot Curtius rearrangement approach was used. This allowed direct access to the N-Boc protected 
derivative of this analogue 16g via isocyanate intermediate 15 (Scheme 3).
12
 
 
 
Scheme 3. Synthesis of piperonyl cyclisation precursor 16g.  
 
Reagents and Conditions: a) DBDMH, 4 M NaOH, H2O, r.t., 16 h, 91%; b) dppa, Et3N, CH2Cl2, 0°C 
 r.t., 0.5 h; c) i) silica plug filtration (partial conversion); ii) PhMe, 110°C, 1 h (complete 
conversion); d) 
t
BuOH, 80°C, 16 h, 50% over 3 steps. 
N-Boc-protection of benzylamine hydrochlorides 9b-f, followed by alkylation of the 
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corresponding carbamates 16b-g gave the desired cyclisation precursors 5b-g in good to excellent 
yield (Table 2). 
 
 
Reagents and Conditions: a) Boc2O, Et3N, CH2Cl2, 16 h; b) NaH, 3-bromocyclohexene, DMF, 0°C- 
r.t., 16 h. 
 
Entry Substrate  R=  Yield 16 (%) Yield 5 
(%) 
1 b 4-Me 99 70 
2 c 4-F 88 71 
3 d 5-OMe 85 72 
4 e 4,5-di-OMe 99 84 
5 f 3,4-CH=CH-CH=CH- 90 86 
6 g 4,5-O(CH2)O- - 75 
 
Table 2. Synthesis of Heck cyclisation precursors 5b-g. 
 
With the cyclisation precursors 5b-g in hand we studied their reaction under the neutral 
Herrmann-Beller palladacycle catalysed Heck cyclisation conditions we had previously 
developed (Table 3).
9
 We found that for the majority of substrates, these conditions promoted 
cyclisation to the expected mixture of double bond regioisomers 6-8. However, conversions were 
lower in all cases than that exhibited by the parent Boc substrate 5a (95% in 3 h),
9
 and reaction 
times were longer, especially with the electron-rich aromatics (Table 3, entries 2, 4, 5, 8). For 
piperonyl substrate 5g (Table 3, entry 8) a significant amount of the debrominated starting 
material was recovered, suggesting this substrate was particularly sluggish to react under the 
palladacycle-catalysed conditions. Fortunately, application of our previously developed low 
temperature (
t
Bu3P)2Pd conditions (Table 3, entry 9),
9
 enabled the recovery of the desired product 
mixture 6-8g in 80% yield at r.t., and 99% yield at 50°C (Table 3, entry 10). The regioisomeric 
mixtures of phenanthridine double bond isomers were used in the subsequent investigation of the 
dihydroxylation of the C-ring.
13
  
Molecular models suggested a cupped conformation for the cis-ring junction phenanthridines 6-8; 
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thus it was anticipated that dihydroxylation would be more favoured on the convex face. In order 
to assess the likely diastereoselectivity of the dihydroxylation reaction across the library, parent 
phenanthridines 6-8a were separated by HPLC
14
 and subjected individually to standard 
dihydroxylation conditions (Scheme 4).
15
 Quantitative conversions to the corresponding diols 
were achieved for all three isomers, with diastereoselectivities from 83:17-85:15 as determined 
by 
1
H NMR. The relative stereochemistry of the major product was confirmed as the exo-diol 
using 2D NMR studies.
16
  
 
 
Reagents and Conditions: aryl halide (1 eq), MeNCy2 (4 eq), Herrmann-Beller palladacycle (5 mol%), 
DMF, 140°C. 
 
Entry 5  R=  t (h) Yield 6-8 (%) Ratio
a
 
6:7:8 
1 a H 3 95 36:38:26 
2 b 4-Me 12 76 26:57:17 
3 c 4-F 5 72 27:44:29 
4 d 5-OMe 6 73 36:44:20 
5 e 4,5-di-OMe 12 75 41:32:27 
6 f 3,4-CH=CH-CH=CH- 5 74 42:42:16 
8 g 4,5-O(CH2)O- 24 59 (32)
b
 41:26:33 
9 g 4,5-O(CH2)O- 18 80 (11)
c,d
 18:46:36 
10 g 4,5-O(CH2)O- 18 99
e
 37:39:24 
a
 Ratio identified from 
1
H NMR of isolated product mixture. 
b
 32% debrominated material recovered. 
c 
Pd2(dba)3 (5 mol%), 
t
Bu3P•HBF4 (10 mol%), MeNCy2 (4 eq), MeCN, r.t.
 d 
Starting material 
recovered. 
e
 As entry 9 but at 50°C.  
Table 3. Heck cyclisation of carbamates 5a-g. 
 
 
Scheme 4. Cis-dihydroxylation of phananthridines 6a-8a. 
Reagents and Conditions: a) OsO4, NMO, THF/H2O, r.t., 18 h (17a 99%; 18a 99%; 19a 99%). 
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When this dihydroxylation protocol was applied to phenanthridine double bond isomer mixtures 
6-8a-g the corresponding diol mixtures 17-19a-g were afforded in good to excellent yield (Table 
4). In keeping with the high diasteromeric ratio we obtained for the cis-dihydroxylation of 
individual carbamates 6-8a, we observed the exo-diols as the major products in all cases.
18
  
 
 
Reagents and Conditions: OsO4, NMO, THF/H2O, r.t., 18 h. 
 
Entry 6-8 R= Yield 17-19 (%)
a
 
1 a H 70 
2 b 4-Me 78 
3 c 4-F 82 
4 d 5-OMe 95 
5 e 4,5-di-OMe 70 
6 f 3,4-CH=CH-CH=CH- 87 
7 g 4,5-O(CH2)O- 87
b 
a
 Isolated yield of mixture following flash chromatography. 
b
 includes 2% 2,3 endo-syn diol product 
as characterised by 2D NMR studies.
15
 
Table 4. Cis-dihydroxylation of phenanthridines 6-8a-g. 
 
Following dihydroxylation, samples of the three major products exo-syn diols 17, 18 and 19 were 
successfully isolated by silica-gel chromatography or HPLC separation. However, we were 
unable to separate the 4-methyl diol products 17b-19b under a range of conditions. Similarly, the 
HPLC fractions for the 1,2 and 2,3 dimethoxy analogues 17e and 18e overlapped significantly, 
and thus the 2,3 sample had significant 1,2 contamination. For these two substrates, mixtures of 
the appropriate compounds were carried through to the biological testing stage.  
For the last step in our library synthesis, we took the diol mixtures and isolated compounds and 
converted each into the hydrochloride salts, with yields as summarised in Table 5. This afforded 
18 isolated compounds and 5 mixtures for biological testing. 
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Reagents and Conditions: i) TFA, CH2Cl2, 1 h, r.t.; ii) NaOH, adjust to pH 9; iii) HCl in Et2O, 0°C. 
 
Entry 17-19 R= Yield 
20-22 (%)
a
 
20 
(%) 
21 (%) 22 (%) 
1
b
 a H - 86 60 53 
2 b 4-Me 69 - - - 
3 c 4-F 99 99 86 74 
4 d 5-OMe 89 82 92 84 
5 e 4,5-di-OMe 87 88 60
c
 60 
6
b
 f 3,4-CH=CH-
CH=CH-
 
- 67 61 69 
7 g 4,5-O(CH2)O- 69 61 81  73 
a
 Performed on mixture. 
b
 No diol mixture was deprotected for these analogues as significant isolated 
material was available as compared to the other substrates. 
c
 Approximately 1:1 mixture 1,2:2,3.  
Table 5. Boc-deprotection to phenanthridinium hydrochloride library. 
 
Zebrafish Phenotyping 
Zebrafish (Danio rerio) embryos are transparent for the first five days post fertilisation (dpf), and 
develop outwith the mother’s body, permitting visual inspection of their anatomical development 
to take place.
11
 Fertilised embryos were collected and arrayed in 96 well plates (3 eggs per well; 
from 6 hours post fertlization, hpf) containing embryo buffer (200 L), and then library members 
in their buffer/0.5% DMSO stock solutions (10-100 M for the mixtures, and 1-50 M for the 
isolated compounds), were exchanged for the buffer, one compound or mixture per well.
19
 The 
embryos were incubated at 28.5°C and examined visually for developmental defects
11
 using a 
light-dissecting microscope at 1, 2, 3 and 4 dpf.  
Our preliminary screening was performed using the mixtures of diols where available, so that 
precious isolated material was not wasted. Fluorinated compound mixture 20c-22c was identified 
as causing reproducible embryo death by 1 dpf, and so we examined each component of the 
mixture individually. Analogue 20c (1,2 isomer) was found to interfere reproducibly with 
zebrafish development (as assessed by the head-trunk angle, which may be used as a measure of 
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developmental hours
20
) at concentrations of 100, 50 and 20 M. By almost 70 hpf all fish were 
delayed developmentally in a dose-dependant manner, and exhibited lower than normal 
pigmentation (Figure 2). At 5 dpf, the yolk sack of the fish treated with 100 M 20c was 
significantly larger than that of the control, providing further evidence for delayed development 
(Figure 3). No notable difference from the control was observed in the fish exposed to lower drug 
concentrations at 5 dpf. None of the other compound mixtures or isolated compounds exhibited 
any specific phenotype when tested on the zebrafish embryos. 
 
 
Figure 2. Zebrafish embryos treated with compound 20c are delayed during embryonic development. 
Zebrafish embryos were treated with 20c for three days, and screened for toxicity or developmental 
phenotypes. One compound, 20c, caused a dose-dependent developmental delay. Control treated 
embryos appeared normal (A), and developed pigmentation (dark coloring). The head-trunk angle, 
used as a measure of developmental hours,
20
 indicates that the control animals are aged at 
approximately 61 hpf (148º angle from middle of the ear and eye to the notochord). By comparison, 
zebrafish treated with 20 M concentrations of 20c (B) appear correctly formed but slightly delayed 
in development by about 9 h (head-trunk angle 138º). Embryos treated with 100 M concentrations of 
20c (C) are strongly delayed for development, as indicated by a low head-trunk angle (62º; equivalent 
to approximately 24 hpf). 
 
 
Figure 3. Zebrafish embryos treated with 100 M compound 20c at 5 dpf. Some of the embryos 
treated with 20c underwent development at a similar rate to the control fish, but did not consume their 
yolk (B, red dotted line), as compared to the control treated fish (A, red arrow). This can indicate 
developmental defects in intestinal development, or a more general toxicity to embryonic 
development. 
Page 9 of 18 
Conclusions 
We have demonstrated that libraries based upon the core structure of natural products can be 
fruitful in the chemical genetics quest for the discovery of novel small molecule probes for 
biological processes. The diversity of such libraries can be enhanced by exploiting multi-product-
generating reactions such as the Heck cyclisation, in conjunction with other methodologies that 
enable access to individual library members. Through the development of various aryl cyclisation 
precursors and a highly selective dihydroxylation protocol, we were able to rapidly synthesise a 
small library of novel phenanthridine analogues suitable for biological testing. The preliminary 
evaluation of this library using zebrafish phenotyping has led to the discovery of a novel inhibi tor 
of zebrafish embryonic development. Further biological investigations including cell -based 
assays and affinity chromatography followed by protein micro-sequencing,
21
 should enable 
identification of the target protein and provide an understanding of the mode of action of 
compound 20c at a molecular level. 
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Experimental 
General methods: All non-aqueous reactions were carried out under an atmosphere of nitrogen 
using flame- or oven-dried glassware that was cooled in a dessicator prior to use. Unless 
otherwise noted, starting materials and reagents were obtained from commercial suppliers and 
were used without further purification. Dichloromethane (CH2Cl2) and triethylamine (Et3N) were 
distilled from and stored over calcium hydride under a nitrogen atmosphere. Tetrahydrofuran 
(THF) was distilled from sodium/benzophenone and stored under a nitrogen atmosphere. Diethyl 
ether (Et2O) was dried and purified by passage through activated alumina columns using a solvent 
purification system from www.glasscontour.com. Anhydrous DMF and acetonitrile (MeCN) were 
used as supplied by BakerDRY. Saturated aqueous solutions of inorganic salts are represented as 
(volume, sat. aq.). 
1
H and 
13
C NMR spectra were obtained on Bruker instuments at the stated 
frequency; J values are in Hz. Infra-red spectra were recorded using a Biorad FTS-7 or Perkin-
Elmer Paragon 1000 FT-IR spectrometer as thin films. Electron impact (EI) mass spectra were 
obtained using a Finnigan 4500 mass spectrometer, and electrospray (ESI) and fast atom 
bombardment (FAB) mass spectra were obtained on a Kratos MS50TC mass spectrometer. 
Melting points were determined on a Gallenkamp Electrothermal Melting Point apparatus and are 
uncorrected. Flash chromatography was carried out using Merck Kieselgel 60 (Merck 9385) 
under positive pressure by means of an airline or hand pump. Eluent compositions are quoted as 
v
/v ratios. High performance liquid chromatography (HPLC) was carried out using a Gilson 
instrument fitted with a refractive index detector, using a Spherisorb silica column (length 250 
mm, i.d. 20.0 mm, particle size 5 µm). Flow rates are a quoted for each separation in mL min
-1
.  
2-Bromo-4-fluorobenzamide 11c: A mixture of 2-bromo-4-fluoro benzoic acid (1.00 g, 4.57 mmol) 
and thionyl chloride (15 mL) was heated at 60°C for 3 h. The thionyl chloride was removed under 
reduced pressure and the residue was dissolved in NH4OH (15 mL, conc.) and stirred for 16 h at r.t. 
The reaction mixture was filtered and the precipitate dried on the high vacuum line for several hours 
to afford afford amide 11c as a colourless solid (940 mg, 94%). 
Rf [CH2Cl2:MeOH, 95:5] = 0.4; MP 155°C (H2O); υmax (CHCl3)/cm
-1
 3400 (NH), 1639 (C=O); 
1
H 
NMR δ (360 MHz, CD3OD) 7.50 (1H, dd, Ј 8.4, 5.8, ArH), 7.46 (1H, dd, Ј 8.6, 2.6, ArH), 7.22 (1H, 
td, Ј 8.4, 2.6, ArH); 13C NMR δ (90.6 MHz, CD3OD) 172.6 (C), 164.4 (d, Ј 252.1, C), 136.5 (C), 
131.7 (d, Ј 9.0, CH), 121.7 (d, Ј 25.1, CH), 121.2 (d, Ј 9.9, C), 115.9 (d, Ј 21.7, CH); m/z (FAB, 3-
NOBA) 220 ([
81Br
M+H]
+
, 64 %), 218 ([
79Br
M+H]
+
, 66), 167 (12), 165 (11), 136 (100); HRMS (EI) 
Found: [
81Br
M]
+
, 218.9511. C7H5ON
81
BrF requires 218.9513. Found: [
79Br
M]
+
, 216.9528. 
C7H5ON
79
BrF requires 216.9533. 
2-Bromo-4-fluorobenzonitrile 12c: A mixture of amide 11c (940 mg, 4.30 mmol) and thionyl 
chloride (6 mL) was refluxed at 60°C for 3 h. The reaction was concentrated under reduced 
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pressure to afford nitrile 12c as a colourless solid (840 mg, 97%). 
Rf [hexane:EtOAc, 3:1] = 0.78; MP 76°C (EtOH); υmax (CHCl3)/cm
-1 
2228 (CN); 
1H NMR δ (360 
MHz, CD3OD) 7.88 (1H, dd, Ј 8.6, 5.4, ArH), 7.69 (1H, dd, Ј 8.3, 2.5, ArH), 7.35 (1H, td, Ј 8.6, 
2.5, ArH); 
13C NMR δ (90.6 MHz, CD3OD) 166.4 (d, Ј 259.3, C), 138.0 (d, Ј 10.1, CH), 127.6 (d, 
Ј 10.3, C), 122.5 (d, Ј 26.1, CH), 117.6 (C), 117.3 (d, Ј 22.9, CH), 113.5 (C); m/z (FAB, 3-
NOBA) 202 ([
81Br
M+H]
+
, 3 %), 200 ([
79Br
M+H]
+
, 2), 154 (64), 121 (11); HRMS (EI) Found: 
[
81Br
M]
+
, 200.9407. C7H3
81
BrFN requires 200.9407. Found: [
79Br
M]
+
, 198.9422. C7H3
79
BrFN 
requires 198.9427. 
2-Bromo-4-fluorobenzylamine hydrochloride 9c: To a suspension of LiAlH4 (95 mg, 2.50 
mmol) in Et2O (5 mL) was added AlCl3 (334 mg, 2.50 mmol) and the mixture was cooled to 0°C 
and stirred for 10 mins. The reaction was warmed to r.t., nitrile 12c (249 mg, 1.25 mmol) was 
added portionwise, the reaction was stirred for 30 mins and then heated at 40°C for 18 h. The 
reaction was quenched by the addition of Na2SO4.5H2O portionwise, filtered and the filtrate 
stirred vigorously with potassium sodium tartrate (100 mL, sat. aq.) for 1 h. The Et2O layer was 
separated and the aqueous phase extracted with Et2O (3  60 mL). The combined organic phases 
were dried (MgSO4) and concentrated under reduced pressure. The residue was taken up in 
CH2Cl2 (1 mL), and HCl in Et2O (20.0 mL, 1 M in Et2O) was added. The precipitate was removed 
by filtration and dried to afford amine hydrochloride 9c as a colourless solid (210 mg, 70%). 
MP 251°C (Et2O); 
1H NMR δ (250 MHz, CD3OD) 7.63 (1H, dd, Ј 8.8, 6.0, ArH), 7.58 (1H, dd, Ј 
8.3, 2.8, ArH), 7.28 (1H, td, Ј 8.5, 2.8, ArH), 4.29 (2H, s, CH2); 
13C NMR δ (62.9 MHz, CD3OD) 
163.5 (d, Ј 252.4, C), 133.1 (d, Ј 9.0, CH), 129.6 (C), 125.3 (d, Ј 10.3, C), 120.9 (d, Ј 25.1, CH), 
115.9 (d, 21.6, CH), 42.8 (CH2); m/z (FAB, 3-NOBA) 206 ([
81Br
M+H]
+
, 14 %), 204 ([
79Br
M+H]
+
, 
17), 189 (37), 187 (40), 149 (47); HRMS (ESI+, CH2Cl2/MeOH/NH4OAc) Found: [M+H]
+
, 
203.9820. C7H8NF
79
Br requires 203.9819. Free Amine: Rf [CH2Cl2:MeOH, 95:5] = 0.46; υmax 
(CHCl3)/cm
-1 
3285 (NH), 2926, 1597, 1484; 
1H NMR δ (250 MHz, CDCl3) 7.33 (1H, dd, Ј 8.5, 
6.0, ArH), 7.26 (1H, dd, Ј 8.3, 2.5, ArH), 6.98 (1H, td, Ј 8.3, 2.5, ArH), 3.85 (2H, s, CH2); 
13
C 
NMR δ (62.9 MHz, CDCl3) 160.6 (d, Ј 249.3, C), 137.4 (C), 129.1 (d, Ј 7.9, CH), 122.6 (d, Ј 9.6, 
C), 119.1 (d, Ј 24.8, CH), 113.9 (d, Ј 20.8, CH), 45.4 (CH2). 
2-Bromo-4-fluorobenzyl tertbutylcarboxamide 16c: A solution of amine hydrochloride 9c (167 
mg, 0.69 mmol) and Et3N (195 µl, 1.39 mmol) in CH2Cl2 (8 mL) was stirred for 10 mins then 
cooled to 0°C. Boc2O (167 mg, 0.76 mmol) was added and the reaction mixture was allowed to 
warm to r.t. and stirred for 4 h. The reaction was diluted with CH2Cl2 (15 mL) and washed with 
NaCl (3  15 mL, sat. aq.). The organics were combined, dried (MgSO4), concentrated under 
reduced pressure and purified by flash chromatography (hexane:EtOAc, 10:1) to afford carbamate 
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16c as a colourless oil (184 mg, 88%).  
Rf [hexane:EtOAc, 3:1] = 0.85; υmax (CHCl3)/cm
-1 
3343 (NH), 1696 (C=O); 
1H NMR δ (250 MHz, 
CDCl3) 7.35 (1H, dd, Ј 8.3, 6.0, ArH), 7.27 (1H, dd, Ј 8.3, 2.5, ArH), 6.99 (1H, dt, Ј 8.3, 2.5, 
ArH), 5.11 (1H, br s, CHN), 4.33 (2H, d, Ј 6.3, CH2Ar), 1.44 (9H, s, 3CH3); 
13C NMR δ (62.9 
MHz, CDCl3) 163.4 (C), 157.5 (d, Ј 245.8, C), 133.8 (C), 130.5 (d, Ј 7.8, CH), 123.2 (d, Ј 9.6, 
C), 119.8 (d, Ј 24.5, CH), 114.4 (d, Ј 20.9, C), 79.6 (C), 44.0 (CH2), 28.2 (3CH3); m/z (EI) 306 
([
81Br
M+H]
+
, 1 %), 304 ([
79Br
M+H]
+
, 1), 248 (14), 246 (13), 189 (17), 187 (18) 168 (100); HRMS 
(EI) Found: [
79Br
M]
+
, 303.0279. C12H15
79
BrFNO2 requires 303.0265. 
2-Bromo-4-fluorobenzyl cyclohex-2-enyl-carbamic acid tert-butyl ester 5c: A solution of Boc 
carbamate 16c (175 mg, 0.56 mmol) in DMF (4 mL) was cooled to 0°C and NaH (46 mg, 60% 
dispersion in mineral oil, 1.15 mmol) was added. The reaction was warmed to r. t. for 40 mins, 
then cooled to 0°C and and 3-bromocyclohexene (133 µl, 1.15 mmol) was added dropwise. The 
reaction allowed to warm to r.t. and stirred for 16 h. Et2O (10 mL) was added and the organics 
washed with NaCl (3  15 mL, sat. aq.). The organics were dried (MgSO4), concentrated under 
reduced pressure and purified by flash chromatography (hexane:EtOAc, 100:1) to afford 
cyclohexenyl amine 5c as a colourless oil (157 mg, 71%). 
Rf [hexane:EtOAc, 3:1] = 0.75; υmax (CHCl3)/cm
-1
1694 (C=O); 
1H NMR δ (360 MHz, 323 K, 
CDCl3) 7.29-7.22 (2H, m, 2ArH), 7.01 (1H, dt, Ј 8.4, 2.6, ArH), 5.86-5.84 (1H, m, CH=CH), 
5.46 (1H, d, Ј 10.2, CH=CH), 4.83 (1H, br s, CHN), 4.30-4.26 (2H, m, CH2Ar), 2.06-1.85 (3H, m, 
CH2+CHAHB), 1.79-1.73 (1H, m, CHAHB), 1.70-1.55 (1H, m, CHCHD), 1.55-1.20 (10H, m, 
CHCHD+3CH3); 
13C NMR δ (90.6 MHz, 323 K, CDCl3) 161.0 (d, Ј 249.0, C), 155.7 (C), 135.0 
(C), 131.4 (CH), 128.5 (CH), 128.0 (CH), 121.7 (d, Ј 9.5, C), 119.4 (d, Ј 24.5, CH), 114.1 (d, Ј 
20.9, CH), 79.9 (C), 53.1 (CH), 47.0 (CH2), 28.2 (3CH3), 28.1 (CH2), 24.5 (CH2), 21.3 (CH2); 
m/z (FAB, 3-NOBA) 386 ([
81Br
M+H]
+
, 86 %), 384 ([
79Br
M+H]
+
, 95), 330 (98), 328 (98), 301 (47), 
299 (49), 284 (96), 282 (97), 250 (96), 248 (97), 246 (94), 204 (77), 202 (87); HRMS (FAB, 3-
NOBA) Found: [
79Br
M]
+
, 384.0969. C18H24
79
BrFNO2 requires 384.0969. 
Fluoro phenanthridines 6-8c: To a degassed solution of cyclohexene 5c (80 mg, 0.21 mmol) in 
DMF was added the Herrmann-Beller palladacycle (10 mg, 10 µmol) and MeNCy2 (175 µl, 0.84 
mmol), and the reaction was heated at 140°C for 5 h. The mixture was allowed to cool and then 
diluted with Et2O (20 mL) and washed with NaCl (3  20 mL, sat. aq.). The organics were combined, 
dried (MgSO4) and concentrated under reduced pressure to give the crude product. Flash 
chromatography (hexane:EtOAc, 100:1-100:6) afforded phenanthridines 6-8c as a colourless oil (46 
mg, 72%). 
1
H NMR of this oil showed it to be a 27: 44: 29 mixture of double bond isomers (6c:7c:8c).  
(4aSR,10bSR)-9-Fluoro-4,4a,6,10b-tetrahydro-3H-phenanthridine-5-carboxylic acid tert-
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butyl ester 6c (Δ1,2 isomer):Rf [hexane:EtOAc, 3:1] = 0.57; υmax (CHCl3)/cm
-1
 1692 (C=O); 
1
H 
NMR δ (360 MHz, 323 K, CDCl3) 7.07 (1H, dd, Ј 8.4, 5.7, ArH), 7.00 (1H, dd, Ј 9.9, 2.6, ArH), 
6.88 (1H, td, Ј 8.4, 2.6, ArH), 6.12-6.06 (1H, m, CHCH=CH), 5.89-5.87 (1H, m, CH=CHCH2), 
4.65 (1H, d, Ј 16.3, CHXHYAr), 4.40 (1H, br s, NCHCH), 4.36 (1H, d, Ј 16.3, CHXHYAr), 3.53 
(1H, br s, NCHCH), 2.31-2.18 (1H, m, CHAHB), 2.17-2.08 (1H, m, CHAHB), 1.77-1.68 (1H, m, 
CHCHD), 1.53-1.46 (10H, m, 3CH3+CHCHD); 
13C NMR δ (90.0 MHz, 323 K, CDCl3) 161.9 (d, Ј 
244.1, C), 154.6 (C), 140.0 (d, Ј 6.8, C), 129.0 (CH), 127.5 (d, Ј 8.0, CH), 126.5 (CH), 123.4 (C), 
114.4 (d, Ј 22.1, CH), 113.0 (d, Ј 21.8, CH), 79.8 (C), 50.2 (CH), 43.0 (CH2), 37.3 (CH), 28.5 
(3CH3), 25.4 (CH2), 24.0 (CH2); m/z (EI) 303 ([M]
+
, 8 %), 247 (95), 246 (90), 202 (27), 193 
(100), 148 (36); HRMS (EI) Found: [M]
+ 
303.1626. C18H22FNO2 requires 303.1629. Diagnostic 
1
H NMR data for 7c (2,3 isomer) 1H NMR δ (360 MHz, 323 K, CDCl3) 7.12 (1H, dd, Ј 8.3, 5.7, 
ArH), 6.94 (1H, d, Ј 10.5, ArH), 6.92-6.87 (1H, m, ArH), 5.69-5.66 (1H, m, CH=CH), 5.46-5.41 
(1H, m, CH=CH), 4.57 (1H, d, Ј 16.2, CHXHY), 4.46 (1H, br s, NCH), 4.45 (1H, d, Ј 16.1, 
CHXHY), 3.18 (1H, s, NCHCH), 2.79-2.73 (1H, m, CHAHB), 2.67-2.60 (1H, m, CHAHB), 2.27-
2.20 (1H, m, CHCHD), 1.53-1.45 (10H, m, CHCHD+3CH3). Diagnostic 
1
H NMR data for 8c 
(3,4 isomer) 1H NMR δ (360 MHz, 323 K, CDCl3); 5.69-5.66 (1H, m, CH=CH), 5.52 (1H, dd, Ј 
10.2, 1.0, CH=CH), 5.08 (1H, br s, NCH), 4.84 (1H, d, Ј 16.4, CHXHY), 4.19 (1H, d, Ј 16.4, 
CHXHY), 3.28 (1H, br s, NCHCH), 2.40-2.30 (1H, m, CHAHB), 2.12-2.00 (1H, m, CHAHB). 
9-Fluoro-3,4-dihydroxy-2,3,4,4a,6,10b-hexahydro-1H-phenanthridine-5-carboxylic acid tert-
butyl ester 17-19c: To a solution of phenanthridines 6-8c (50 mg, 0.165 mmol) in THF (920 µl) 
and H2O (184 µl) was added OsO4 (144 µl, 2.5% 
w
/w in 
t
BuOH, 11.5 µmol) and NMO (58 mg, 
0.495 mmol) and the reaction was stirred for 16 h at r.t. The reaction mixture was poured onto 
Na2SO3 (30 mL, sat. aq.) and extracted with EtOAc (3  30 mL). The combined organics were 
dried (MgSO4), concentrated under reduced pressure and purified by flash chromatography 
(CH2Cl2:MeOH, 100:2) to afford a mixture of diols 17-19c (46 mg, 82%). HPLC (EtOAc:hexane, 
3:1) of this mixture afforded Δ1,2 diol 17c (10 mg, 18%), Δ2,3 diol 18c (15.3 mg, 2%), Δ3,4 diol 19c 
(11.4 mg, 20%), and mixed diol fractions (9 mg, 16%) giving an overall yield (45.7 mg, 82%), all 
colourless oils. 
(1RS,2SR,4aSR,10bSR)-9-Fluoro-1,2-dihydroxy-2,3,4,4a,6,10b-hexahydro-1H-
phenanthridine-5-carboxylic acid tert-butyl ester 17c (1,2 isomer): Rf [CH2Cl2:MeOH, 9:1] = 
0.43; Rt (EtOAc:hexane, 3:1, flow rate: 10 mL min
-1) = 15 min; υmax (CHCl3)/cm
-1
3425 (OH), 
1664 (C=O); 
1H NMR δ (360 MHz, 323 K, CDCl3) 7.13-7.04 (2H, m, 2ArH), 6.92 (1H, td, Ј 
10.9, 2.6, ArH), 4.70-4.62 (3H, m, 2CH+CHXHYAr), 4.31 (1H, d, Ј 16.9, CHXHYAr), 3.73-3.68 
(1H, m, CH), 3.37 (1H, br s, CH), 2.51 (1H, br s, OH), 1.92-1.84 (1H, m, CHAHB), 1.70-1.52 (2H, 
m, CHAHB+CHCHD), 1.51 (9H, s, 3CH3), 1.41-1.32 (1H, m, CHCHD); 
13C NMR δ (90.6 MHz, 
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323 K, CDCl3) 161.9 (d, Ј 245.2, C), 154.8 (C), 135.3 (d, Ј 6.9, C), 129.1 (C), 128.1 (d, Ј 8.2, 
CH), 113.5 (d, Ј 21.7, CH), 112.5 (d, Ј 22.4, CH), 80.1 (C), 71.1 (CH), 67.4 (CH), 46.9 (CH), 
43.0 (CH2), 42.9 (CH), 28.4 (3CH3), 27.3 (CH2), 24.2 (CH2); m/z (EI) 337 ([M]
+
, 1 %), 280 ([M-
t
Bu]
+
, 100), 236 ([M-Boc]
+
, 61), 192 (19), 162 (26). 
(2RS,3SR,4aSR,10bSR)-9-Fluoro-2,3-dihydroxy-2,3,4,4a,6,10b-hexahydro-1H-
phenanthridine-5-carboxylic acid tert-butyl ester 18c (2,3 isomer): Rf [CH2Cl2:MeOH, 9:1] = 
0.53; Rt (EtOAc:hexane, 3:1, flow rate: 10 mL min
-1) = 20 min; υmax (CHCl3)/cm
-1
 3421 (OH), 
1670 (C=O); 
1H NMR δ (360 MHz, 323 K, CDCl3) 7.17 (1H, d, Ј 10.1, ArH), 7.11-7.07 (1H, m, 
ArH), 6.91 (1H, td, Ј 8.3, 1.8, ArH), 4.80-4.72 (1H, m, CH), 4.66 (1H, d, Ј 17.0, CHXHYAr), 4.31 
(1H, d, Ј 17.0, CHXHYAr), 3.93 (1H, br s, CH), 3.64-3.60 (1H, m, CH), 3.23 (1H, br s, CH), 2.40-
2.23 (2H, m, CH2), 1.92-1.89 (1H, m, CHAHB), 1.52 (9H, s, 3CH3), 1.50-1.42 (1H, m, CHAHB); 
13C NMR δ (62.9 MHz, CDCl3) 164.9 (d, Ј 133.4, C), 154.7 (C), 136.8 (C), 128.6 (C), 127.9 (d, Ј 
8.3, CH), 113.4 (d, Ј 21.6, CH), 112.5 (d, Ј 21.9, CH), 80.2 (C), 69.1 (CH), 66.6 (CH), 46.3 (CH), 
42.8 (CH2), 36.4 (CH), 31.3 (CH2), 29.1 (CH2), 28.4 (3CH3); m/z (EI) 337 ([M]
+
, 1 %), 280 ([M-
t
Bu])
+
, 100), 236 ([M-Boc]
+
, 27), 218 (19), 192 (35), 162 (34), 148 (24). 
(3RS,4SR,4aRS,10bSR)-9-Fluoro-3,4-dihydroxy-2,3,4,4a,6,10b-hexahydro-1H-
phenanthridine-5-carboxylic acid tert-butyl ester 19c (3,4 isomer): Rf [CH2Cl2:MeOH, 9:1] = 
0.47; Rt (EtOAc:hexane, 3:1, flow rate: 8 mL min
-1) = 17 min; υmax (CHCl3)/cm
-1
 3404 (OH), 
1670 (C=O); 
1H NMR δ (360 MHz, 323 K, CDCl3) 7.11 (1H, dd, Ј 8.5, 5.7, ArH), 7.03 (1H, dd, Ј 
10.0, 1.7, ArH), 6.92 (1H, m, ArH), 4.73-4.61 (2H, m, CH+CHXHYAr), 4.41 (1H, d, Ј 16.4, 
CHXHYAr), 3.96 (1H, d, Ј 2.7, CH), 3.30-3.25 (2H, m, 2CH), 2.60 (1H, br s, OH), 2.35-2.22 
(1H, m, CHAHB), 2.17-2.12 (1H, m, CHAHB), 1.87-1.82 (1H, m, CHCHD), 1.60-1.50 (10H, m, 
CHCHD+3CH3); 
13C NMR δ (90.6 MHz, 323 K, CDCl3) 162.1 (d, Ј 245.1, C), 155.2 (C), 137.1 
(d, Ј 2.8, C), 128.9 (C), 128.0 (d, Ј 8.2, CH), 113.4 (d, Ј 21.7, CH), 112.3 (d, Ј 22.1, CH), 81.0 
(C), 69.5 (2CH), 52.7 (CH), 42.1 (CH2), 37.1 (CH), 28.4 (3CH3), 25.4 (CH2), 20.1 (CH2); m/z 
(EI) 337 ([M]
+
, 1 %), 281 (36), 280 ([M-
t
Bu])
+
, 9), 236 ([M-Boc]
+
, 100), 218 (11), 206 (12), 192 
(13), 162 (40). 
(1RS,2SR,4aSR,10bSR)-9-Fluoro-1,2,3,4,4a,5,6,10b- octahydro-phenanthridine-1,2-diol 20c 
(Δ1,2 isomer): To a solution of diol 17c (10 mg, 30 µmol) in CH2Cl2 (2 mL) was added TFA (5 
mL) and the reaction was stirred at r.t. for 2 h. The reaction was diluted with H 2O (15 mL), 
adjusted to pH 8-9 by the addition of NaOH pellets, and then extracted with CH2Cl2 (3  15 mL). 
The combined organics were dried (MgSO4) and concentrated under reduced pressure. The 
resultant oil was taken up in CH2Cl2 (1 mL), cooled to 0°C and HCl (excess, 1 M in Et2O) added. 
The resultant oil was washed with Et2O and dried under vacuum to afford amine hydrochloride 
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20c as a colourless oil (9 mg, 99%). 
1
H NMR δ (360 MHz, D2O) 7.09 (1H, dd, Ј 8.6, 5.7, ArH), 7.03 (1H, dd, Ј 10.2, 2.6, ArH), 6.94 
(1H, td, Ј 8.6, 2.6, ArH), 4.28 (1H, d, Ј 16.2, CHXHYAr), 4.22 (1H, d, Ј 16.2, CHXHYAr), 3.88 
(1H, d, Ј 7.6, CH), 3.78-3.74 (2H, m, 2CH), 3.19 (1H, dd, Ј 8.2, 4.4, CH), 2.01-1.91 (1H, m, 
CHAHB), 1.81-1.72 (1H, m,CHAHB), 1.68-1.60 (2H, m, CH2); 
13C NMR δ (90.6 MHz, D2O) 162.3 
(d, Ј 243.8, C), 135.0 (d, Ј 7.7, C), 129.2 (d, Ј 8.5, CH), 123.7 (C), 116.4 (d, Ј 23.7, CH), 115.5 
(d, Ј 22.1, CH), 70.9 (CH), 68.2 (CH), 52.0 (CH), 43.4 (CH2), 39.5 (CH), 25.6 (CH2), 21.9 (CH2); 
m/z (ESI+) 238 ([M+H]
+
, 100 %), 236 (86); HRMS (ESI+) Found [M+H]
+
, 238.1237. 
C13H17O2NF requires 238.1238. 
Zebrafish screening: Small breeding tanks were set up in the evening, each containing a male and a 
female wildtype zebrafish separated by a divider. The tanks were kept in darkness until the next 
morning when the lights were switched on and the dividers removed, causing the fish to breed. The 
embryos were collected, pooled and washed with E3 medium. Dead, delayed or unfertilised eggs were 
discarded, and the adult fish were returned to their main tank. The embryos were stored in an 
incubator at 28.5°C until required they reached the ‘high stage’ of development (approxiately 3.3 hpf). 
Chemicals were diluted into the E3 screening medium.
19
 Aliquots of 200 L were prepared at 
concentrations ranging from 100 M to 1 M, all with 0.5% v/v DMSO. Once the embryos had 
reached the desired age they were distributed in 96-well plates as appropriate to the screen, with two 
or three embryos per well. The surrounding medium was removed from the embryos using a wide-
tipped Pasteur pipette and then the appropriate 200 L chemical aliquot was added to the well. Four 
control wells were used per plate, each containing E3 medium with 0.5% 
v
/v DMSO. The plates were 
incubated at 28.5°C and examined periodically over the next five days by optical microscope.  
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